|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||758.08 - 779.00|
|52 Week Range||538.01 - 779.00|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||16.32|
|Earnings Date||Feb 02, 2023 - Feb 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||802.25|
Subscribe to Yahoo Finance Plus to view Fair Value for REGN
It's not a stretch to say that Regeneron Pharmaceuticals, Inc.'s ( NASDAQ:REGN ) price-to-earnings (or "P/E") ratio of...
The list includes Regeneron Pharmaceuticals (NASDAQ: REGN) and Biogen (NASDAQ: BIIB). Regeneron was having an unimpressive year on the stock market until its shares soared by double-digit percentages in one day in September. As is often the case with biotechs, Regeneron owes this move to positive clinical developments.
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...